Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Glutaredoxin pseudogene 1 (GLRXP1)
- Target
- GLRXP1
- Molecular classification
- Pseudogene, Has homology with thioltransferase enzymes (glutaredoxins) but lacks catalytic function
01
Overview
Glutaredoxin pseudogene 1 (GLRXP1) is a human non-coding pseudogene, homologous to the glutaredoxin (thioltransferase) family, but lacking catalytic activity due to disabling mutations[4][2]. Unlike functional glutaredoxins (such as Glutaredoxin-1, GLRX), GLRXP1 does not produce an enzyme and therefore has no direct biochemical functions. Some pseudogenes can play regulatory roles at the RNA level, potentially acting as miRNA "sponges" or affecting gene expression through sequence homology, but no specific regulatory mechanism or disease association has been established for GLRXP1[2][5]. GLRXP1 is commonly annotated in genomic databases but is not considered a valid therapeutic target.
- Other names
- bA425M5.1
02
Mechanism of action
Not applicable; no drugs target this pseudogene.
03
Biological functions
Pseudogenes may have regulatory functions such as serving as miRNA decoys, but GLRXP1 has no known direct protein or enzymatic activityMay participate in gene expression regulation via sequence similarity or miRNA interaction if expressed, but no specific activity data are available for GLRXP1
04
Disease associations
Most pseudogenes are not directly implicated in disease, but pseudogenes can sometimes regulate parental gene expression in cancer or other diseasesNo specific roles for GLRXP1 documented
05
Safety considerations
None specific to GLRXP1, as it is non-coding and not used therapeutically.
06
Interacting drugs
None. As a pseudogene, GLRXP1 does not directly interact with drugs
07
Biomarkers
None reported for GLRXP1
Beyond the preview
Go deeper on Glutaredoxin pseudogene 1 (GLRXP1).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Glutaredoxin pseudogene 1 (GLRXP1).